Pr Yohann Loriot
- Spécialité
- Oncologue médical, expert urologie
- Titre
- Chef adjoint du département des Essais Précoces (DITEP)
- Hôpital
- Gustave Roussy (Villejuif)
- Derniers articles
-
- Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade. (9 déc. 2024)
- Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers. (4 déc. 2024)
- Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases. (1 nov. 2024)
- Cisplatin- or Carboplatin-Based Chemotherapy Plus Pembrolizumab in Advanced Urothelial Cancer: Exploratory Analysis From the Phase 3 KEYNOTE-361 Study. (1 nov. 2024)
- Author Correction: The genomic and transcriptomic landscape of metastastic urothelial cancer. (30 oct. 2024)